The VERSANT® HCV RNA Qualitative Assay* is based on state-of-the-art Transcription-Mediated Amplification (TMA) technology. TMA technology allows the VERSANT HCV RNA Qualitative Assay to provide maximum sensitivity for the detection of the hepatitis C virus (HCV) in infected patients.
- Most Sensitive Detection*
- Highly Specific Assay
- Reliable Performance
- High-Throughput Processing
- Easy-to-Use Technology